Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus
Top Cited Papers
- 1 October 2020
- Vol. 69 (12), 2093-2112
- https://doi.org/10.1136/gutjnl-2020-322368
Abstract
Objective A global consensus meeting was held to review current evidence and knowledge gaps and propose collaborative studies on population-wide screening and eradication of Helicobacter pylori for prevention of gastric cancer (GC). Methods 28 experts from 11 countries reviewed the evidence and modified the statements using the Delphi method, with consensus level predefined as ≥80% of agreement on each statement. The Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach was followed. Results Consensus was reached in 26 statements. At an individual level, eradication of H. pylori reduces the risk of GC in asymptomatic subjects and is recommended unless there are competing considerations. In cohorts of vulnerable subjects (eg, first-degree relatives of patients with GC), a screen-and-treat strategy is also beneficial. H. pylori eradication in patients with early GC after curative endoscopic resection reduces the risk of metachronous cancer and calls for a re-examination on the hypothesis of ‘the point of no return’. At the general population level, the strategy of screen-and-treat for H. pylori infection is most cost-effective in young adults in regions with a high incidence of GC and is recommended preferably before the development of atrophic gastritis and intestinal metaplasia. However, such a strategy may still be effective in people aged over 50, and may be integrated or included into national healthcare priorities, such as colorectal cancer screening programmes, to optimise the resources. Reliable locally effective regimens based on the principles of antibiotic stewardship are recommended. Subjects at higher risk of GC, such as those with advanced gastric atrophy or intestinal metaplasia, should receive surveillance endoscopy after eradication of H. pylori. Conclusion Evidence supports the proposal that eradication therapy should be offered to all individuals infected with H. pylori. Vulnerable subjects should be tested, and treated if the test is positive. Mass screening and eradication of H. pylori should be considered in populations at higher risk of GC.Keywords
Funding Information
- Takeda Taiwan Co. Ltd (GEST APTC-01)
- Ministry of Education (MOE) in Taiwan (NTU-107L9014-1)
- Ministry of Health and Welfare of Taiwan (MOHW107-TDU-B-211-123002, MOHW108-CDC-C-114-112102)
- the Swiss Pharmaceutical Co., Ltd (NA)
- Australian Federal Government to the St George and Sutherland Medical Research Foundation.
- the Liver Disease Prevention & Treatment Research Foundation, Taiwan (NA)
- the Eisai Co. Ltd (NA)
- Texas Medical Center Digestive Diseases Center (NA)
- the Harvester Trading Co. LTD. (NA)
- the Panion & BF Biotech Inc. (NA)
- National Taiwan University Hospital (NTUH 107-P05; NTUH 109-P03)
- Gastroenterological Society of Taiwan
- Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service (DK56338)
- Ministry of Science and Technology of Taiwan (TCTC 108-2321-B-002 -040 - and MOST 108-2314-B-002)
This publication has 143 references indexed in Scilit:
- Accuracy of faecal occult blood test andHelicobacter pyloristool antigen test for detection of upper gastrointestinal lesionsBMJ Open, 2013
- Association between Helicobacter pylori and asthmaEuropean Journal of Gastroenterology & Hepatology, 2013
- The benefit of mass eradication ofHelicobacter pyloriinfection: a community-based study of gastric cancer preventionGut, 2012
- Fifteen-Year Effects of Helicobacter pylori, Garlic, and Vitamin Treatments on Gastric Cancer Incidence and MortalityJNCI Journal of the National Cancer Institute, 2012
- Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study CohortBritish Journal of Cancer, 2011
- The effect of Helicobacter pylori on asthma and allergyJournal of Asthma and Allergy, 2010
- Cost-Effectiveness of Eradication ofHelicobacter pyloriin Gastric Cancer Survivors After Endoscopic Resection of Early Gastric CancerHelicobacter, 2009
- High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of ObesityGastroenterology, 2009
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trialThe Lancet, 2008
- Helicobacter pyloriInfection and the Development of Gastric CancerThe New England Journal of Medicine, 2001